Portal de Periódicos da CAPES

Cancer estimation of incidence and survival in Algeria 2014

2015; NobleResearch Publishers; Volume: 3; Issue: 9 Linguagem: Inglês

10.14312/2052-4994.2015-14

2052-4994

Hamdi Cherif M, Ettore Bidoli, Silvia Birri, A. Mahnane, Zoubida Zaidi, H. Boukharouba, H Moussaoui, Rengaswamy Sankaranarayanan, A Ayat, Kenza Makhloufi, Imane Bouchaibi, Saverio Virdone, Diego Serraino,

Colorectal Cancer Screening and Detection

Cancer is one of the major public health problems in Algeria.In the last 25 years, a significant increase in the incidence of the major types of cancers has been observed in both sexes.Moreover, the 5-year survival rate is low for the severe tumors due to a difficulty in access to cancer care and an incomplete health care framework.Cancer Registry of Setif, Algeria, has been recording cancer incidence, mortality, and survival since 1986 in collaboration with International Agency for Research on Cancer (IARC) of Lyon.Cancer Registry of Setif is being a source of information for cancer planning and corresponding surveillance in the National Cancer Plan 2015-2019, starting in January 2015.Data is recorded by means of CanReg 5 software.This software is developed and provided by the International Agency for Research on Cancer (IARC) of Lyon.It is designed specifically for cancer registration, and standardized to capture, control, and process the data.Estimation of cancer incidence in Algeria and survival rates are very important for surveillance, control, and planning of care.In men the incidence of lung, colorectal, bladder, prostate, and laryngeal cancers has significantly and steadily increased in the last decade.In women, the incidence of breast, colorectal, thyroid, and lung cancers has also increased significantly in the same period.Five-year survival rates for cancer of the stomach, colon, rectum, liver, lung, breast, cervix, ovary, and prostate in adults, and childhood leukemia are relatively low compared with other countries.The aim of our study was to estimate incidence and survival by means of Setif cancer registry data.